Kim TD - Search Results

1

Quintás-Cardama A, Kim TD, Cataldo V, le Coutre P. Quintás-Cardama A, et al. Among authors: kim td. Recent Results Cancer Res. 2010;184:103-17. doi: 10.1007/978-3-642-01222-8_8. Recent Results Cancer Res. 2010. PMID: 20072834 Review.

2

Nilotinib for the treatment of chronic myeloid leukemia.

Kim TD, Dörken B, le Coutre P. Kim TD, et al. Expert Rev Hematol. 2008 Oct;1(1):29-39. doi: 10.1586/17474086.1.1.29. Expert Rev Hematol. 2008. PMID: 21083005

3

The expanding role of nilotinib in chronic myeloid leukemia.

Kim TD, le Coutre P. Kim TD, et al. Expert Opin Drug Saf. 2011 Jan;10(1):97-107. doi: 10.1517/14740338.2011.532486. Epub 2010 Dec 2. Expert Opin Drug Saf. 2011. PMID: 21121868 Review.

4

Omacetaxine mepesuccinate for the treatment of leukemia.

Kim TD, Frick M, le Coutre P. Kim TD, et al. Expert Opin Pharmacother. 2011 Oct;12(15):2381-92. doi: 10.1517/14656566.2011.613378. Expert Opin Pharmacother. 2011. PMID: 21916787

5

Clinical cardiac safety profile of nilotinib.

Kim TD, le Coutre P, Schwarz M, Grille P, Levitin M, Fateh-Moghadam S, Giles FJ, Dörken B, Haverkamp W, Köhncke C. Kim TD, et al. Haematologica. 2012 Jun;97(6):883-9. doi: 10.3324/haematol.2011.058776. Epub 2012 Jan 22. Haematologica. 2012. PMID: 22271904 Free PMC article.

6

Nilotinib.

Ostendorf BN, le Coutre P, Kim TD, Quintás-Cardama A. Ostendorf BN, et al. Among authors: kim td. Recent Results Cancer Res. 2014;201:67-80. doi: 10.1007/978-3-642-54490-3_3. Recent Results Cancer Res. 2014. PMID: 24756785 Review.

7

Nilotinib.

Gresse M, Kim TD, le Coutre P. Gresse M, et al. Among authors: kim td. Recent Results Cancer Res. 2018;212:69-85. doi: 10.1007/978-3-319-91439-8_3. Recent Results Cancer Res. 2018. PMID: 30069625

8

Impact of additional chromosomal aberrations and BCR-ABL kinase domain mutations on the response to nilotinib in Philadelphia chromosome-positive chronic myeloid leukemia.

Kim TD, Türkmen S, Schwarz M, Koca G, Nogai H, Bommer C, Dörken B, Daniel P, le Coutre P. Kim TD, et al. Haematologica. 2010 Apr;95(4):582-8. doi: 10.3324/haematol.2009.014712. Epub 2009 Dec 16. Haematologica. 2010. PMID: 20015884 Free PMC article.

9

Peripheral artery occlusive disease in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinib.

Kim TD, Rea D, Schwarz M, Grille P, Nicolini FE, Rosti G, Levato L, Giles FJ, Dombret H, Mirault T, Labussière H, Lindhorst R, Haverkamp W, Buschmann I, Dörken B, le Coutre PD. Kim TD, et al. Leukemia. 2013 Jun;27(6):1316-21. doi: 10.1038/leu.2013.70. Epub 2013 Mar 5. Leukemia. 2013. PMID: 23459449

10

Thyroid dysfunction caused by second-generation tyrosine kinase inhibitors in Philadelphia chromosome-positive chronic myeloid leukemia.

Kim TD, Schwarz M, Nogai H, Grille P, Westermann J, Plöckinger U, Braun D, Schweizer U, Arnold R, Dörken B, le Coutre P. Kim TD, et al. Thyroid. 2010 Nov;20(11):1209-14. doi: 10.1089/thy.2010.0251. Epub 2010 Oct 7. Thyroid. 2010. PMID: 20929406

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

298 results

Search Page

Filters